I agree that this site is using cookies. You can find further informations here.
X
Leonart, Letícia P.
37  results:
Search for persons X
?
1

Prognostic Factors, Survival Analyses and the Risk of Secon..:

Della Rocca, Ana M. ; Tonin, Fernanda S. ; Fachi, Mariana M....
Diseases.  9 (2021)  2 - p. 43 , 2021
Link: https://doi.org/10.3390/..
 
?
2

Chemotherapy Treatments for Burkitt Lymphoma: Systematic Re..:

Della Rocca, Ana M. ; Leonart, Letícia P. ; Ferreira, Vinicius L....
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  8 - p. 514-525 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Reliability in long-term clinical studies of disease-modify..:

Lucchetta, Rosa C. ; Leonart, Letícia P. ; Gonçalves, Marcus V. M....
PLOS ONE.  15 (2020)  6 - p. e0231722 , 2020
Link: https://doi.org/10.1371/..
 
?
4

Efficacy and safety of oral phosphodiesterase 5 inhibitors ..:

Madeira, Camilla R. ; Tonin, Fernanda S. ; Fachi, Mariana M....
World Journal of Urology.  39 (2020)  3 - p. 953-962 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Evaluation of the Bronchodilator Effect of Guaco Syrup: a R..:

Garcia, Carolina G. ; Leonart, Letícia P. ; Lenzi, Luana...
Revista Brasileira de Farmacognosia.  30 (2020)  1 - p. 111-117 , 2020
Link: https://doi.org/10.1007/..
 
?
6

Safety outcomes of disease-modifying therapies for relapsin..:

Lucchetta, Rosa C ; Leonart, Letícia P ; Becker, Jefferson...
Multiple Sclerosis and Related Disorders.  35 (2019)  - p. 7-15 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Haematological adverse events associated with tyrosine kina..:

Fachi, Mariana M. ; Tonin, Fernanda S. ; Leonart, Leticia P....
British Journal of Clinical Pharmacology.  85 (2019)  10 - p. 2280-2291 , 2019
Link: https://doi.org/10.1111/..
 
?
8

Comparative efficacy and safety of tyrosine kinase inhibito..:

Fachi, Mariana M. ; Tonin, Fernanda S. ; Leonart, Leticia P....
European Journal of Cancer.  104 (2018)  - p. 9-20 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Methodological quality assessment of network meta-analysis ..:

Tonin, Fernanda S ; Borba, Helena H ; Leonart, Leticia P...
International Journal of Epidemiology.  48 (2018)  2 - p. 620-632 , 2018
Link: https://doi.org/10.1093/..
 
?
10

Discontinuation of non-anti-TNF drugs for rheumatoid arthri..:

Tonin, Fernanda S. ; Steimbach, Laiza M. ; Leonart, Leticia P....
European Journal of Clinical Pharmacology.  74 (2018)  11 - p. 1513-1521 , 2018
Link: https://doi.org/10.1007/..
 
?
11

Effectiveness and safety of pegvisomant: a systematic revie..:

Leonart, Letícia P. ; Tonin, Fernanda S. ; Ferreira, Vinicius L...
Endocrine.  63 (2018)  1 - p. 18-26 , 2018
Link: https://doi.org/10.1007/..
 
?
12

Medical Treatments for Acromegaly: A Systematic Review and ..:

Leonart, Letícia P. ; Ferreira, Vinicius L. ; Tonin, Fernanda S...
Value in Health.  21 (2018)  7 - p. 874-880 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Disease-Modifying Therapies for Relapsing–Remitting Multipl..:

Lucchetta, Rosa C. ; Tonin, Fernanda S. ; Borba, Helena H. L....
CNS Drugs.  32 (2018)  9 - p. 813-826 , 2018
Link: https://doi.org/10.1007/..
 
?
14

Cost-effectiveness of acromegaly treatments: a systematic r..:

Leonart, Letícia P. ; Borba, Helena H. L. ; Ferreira, Vinicius L...
Pituitary.  21 (2018)  6 - p. 642-652 , 2018
Link: https://doi.org/10.1007/..
 
?
15

Prognostic Factors, Survival Analyses and the Risk of Secon..:

Della Rocca, Ana M ; Tonin, Fernanda S ; Fachi, Mariana M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293230/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15